img

Global Antibody Drug Conjugates Contract Manufacturing Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global Antibody Drug Conjugates Contract Manufacturing Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Antibody Drug Conjugates Contract Manufacturing Market
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Antibody Drug Conjugates Contract Manufacturing estimated at US$ 3,301.31 million in the year 2023, is projected to reach a revised size of US$ 9,333.76 million by 2033, growing at a CAGR of 18.91% % during the forecast period 2023-2033.
The US & Canada market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 1,181.54 million in 2023 to reach $ 3,698.97 million by 2033, at a CAGR of 20.95 % during the forecast period of 2024 through 2033.
The China market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 422.57 million in 2023 to reach $ 1,135.92 million by 2033, at a CAGR of 17.92% during the forecast period of 2024 through 2033.
The Europe market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ 924.37 million in 2023 to reach $ 2,625.59 million by 2033, at a CAGR of 19% during the forecast period of 2024 through 2033.
The global key companies of Antibody Drug Conjugates Contract Manufacturing include Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, and Curia, etc. In 2023, the global top five players had a share approximately 68.46 % in terms of revenue.
Report Includes
This report presents an overview of global market for Antibody Drug Conjugates Contract Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2023, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of Antibody Drug Conjugates Contract Manufacturing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antibody Drug Conjugates Contract Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antibody Drug Conjugates Contract Manufacturingrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Antibody Drug Conjugates Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2033. Evaluation and forecast the market size for Antibody Drug Conjugates Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lonza Group, Merck KGaA, Recipharm, Thermo Fisher Scientific, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, and Curia, etc.




By Company


Lonza Group
Merck KGaA
Recipharm
Thermo Fisher Scientific
Abbvie
Piramal Pharma Solutions
Catalent
Sterling Pharma Solutions
Curia
Novasep
Ajinomoto Bio-Pharma Services
BSP Pharmaceuticals
Cerbios-Pharma
Goodwin Biotechnology

Segment by Type
IgG1
IgG4


Segment by Application


Solid Tumors
Hematological Malignancies

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia

Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe

Latin America
Mexico
Brazil
Rest of Latin America

Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA


Chapter Outline



Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Antibody Drug Conjugates Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Antibody Drug Conjugates Contract Manufacturing companies鈥 competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7Europe by Type, by Application and by country, revenue for each segment.
Chapter 8China by Type, and by Application, revenue for each segment.
Chapter 9Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Drug Conjugates Contract Manufacturingrevenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type: 2018 VS 2023 VS 2033 2
1.2.2 IgG1 4
1.2.3 IgG4 5
1.3 Market by Application 5
1.3.1 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2018 VS 2023 VS 2033 5
1.3.2 Solid Tumors 7
1.3.3 Hematological Malignancies 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 9
2 Global Growth Trends 10
2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Perspective (2018-2033) 10
2.2 Global Antibody Drug Conjugates Contract Manufacturing Growth Trends by Region 11
2.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2018 VS 2023 VS 2033 12
2.2.2 Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Region (2018-2023) 13
2.2.3 Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2024-2033) 13
2.3 Antibody Drug Conjugates Contract Manufacturing Market Dynamics 14
2.3.1 Antibody Drug Conjugates Contract Manufacturing Industry Trends 14
2.3.2 Antibody Drug Conjugates Contract Manufacturing Market Drivers 16
2.3.3 Antibody Drug Conjugates Contract Manufacturing Market Challenges 17
3 Competition Landscape by Key Players 18
3.1 Global Revenue Antibody Drug Conjugates Contract Manufacturing by Players 18
3.1.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2018-2023) 18
3.1.2 Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Players (2018-2023) 19
3.2 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 20
3.3 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Ranking by Revenue, 2021 VS 2023 VS 2023 22
3.4 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio 23
3.4.1 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio (CR5 and HHI) 23
3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugates Contract Manufacturing Revenue in 2023 24
3.5 Global Key Players of Antibody Drug Conjugates Contract Manufacturing Head office and Area Served 25
3.6 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application 26
3.7 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Established 27
4 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Type 28
4.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Type (2018-2023) 28
4.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2024-2033) 29
5 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Application 30
5.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Application (2018-2023) 30
5.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2024-2033) 31
6 North America 32
6.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2033) 32
6.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type 32
6.2.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) 32
6.2.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) 33
6.2.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 33
6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application 34
6.3.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) 34
6.3.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) 34
6.3.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 35
6.4 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country 35
6.4.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2023 VS 2033 35
6.4.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) 36
6.4.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2024-2033) 36
6.4.4 United States 37
6.4.5 Canada 38
7 Europe 39
7.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2033) 39
7.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type 39
7.2.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) 39
7.2.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) 40
7.2.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 40
7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application 41
7.3.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) 41
7.3.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) 41
7.3.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 42
7.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country 42
7.4.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2023 VS 2033 42
7.4.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) 43
7.4.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2033) 43
7.4.4 Germany 45
7.4.5 France 45
7.4.6 U.K. 46
7.4.7 Italy 47
7.4.8 Russia 47
7.4.9 Nordic Countries 48
8 China 49
8.1 China Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2033) 49
8.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type 49
8.2.1 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) 49
8.2.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) 50
8.2.3 China Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 50
8.3 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application 51
8.3.1 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) 51
8.3.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) 51
8.3.3 China Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 52
9 Asia (excluding China) 53
9.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2033) 53
9.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type 53
9.2.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) 53
9.2.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) 54
9.2.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 54
9.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application 55
9.3.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) 55
9.3.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) 55
9.3.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 56
9.4 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region 56
9.4.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2018 VS 2023 VS 2033 56
9.4.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023) 57
9.4.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2024-2033) 57
9.4.4 Japan 59
9.4.5 South Korea 59
9.4.6 China Taiwan 60
9.4.7 Southeast Asia 61
9.4.8 India 61
9.4.9 Australia 62
10 Middle East, Africa, and Latin America 63
10.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size (2018-2033) 63
10.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type 63
10.2.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) 63
10.2.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) 64
10.2.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 64
10.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application 65
10.3.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) 65
10.3.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) 65
10.3.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 66
10.4 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country 66
10.4.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2018 VS 2023 VS 2033 66
10.4.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) 67
10.4.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2033) 67
10.4.4 Brazil 69
10.4.5 Mexico 69
10.4.6 Turkey 70
10.4.7 Israel 71
10.4.8 GCC Countries 71
11 Key Players Profiles 73
11.1 Lonza Group 73
11.1.1 Lonza Group Company Details 73
11.1.2 Lonza Group Business Overview 73
11.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Introduction 74
11.1.4 Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 75
11.2 Merck 76
11.2.1 Merck Company Details 76
11.2.2 Merck Business Overview 77
11.2.3 Merck Antibody Drug Conjugates Contract Manufacturing Introduction 77
11.2.4 Merck Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 78
11.3 Recipharm 79
11.3.1 Recipharm Company Details 79
11.3.2 Recipharm Business Overview 80
11.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Introduction 80
11.3.4 Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 81
11.4 Thermo Fisher Scientific 82
11.4.1 Thermo Fisher Scientific Company Details 82
11.4.2 Thermo Fisher Scientific Business Overview 83
11.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Introduction 83
11.4.4 Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 84
11.5 Abbvie 84
11.5.1 Abbvie Company Details 85
11.5.2 Abbvie Business Overview 85
11.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Introduction 85
11.5.4 Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 87
11.6 Piramal Pharma Solutions 88
11.6.1 Piramal Pharma Solutions Company Details 88
11.6.2 Piramal Pharma Solutions Business Overview 89
11.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction 89
11.6.4 Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 91
11.7 Catalent 92
11.7.1 Catalent Company Details 92
11.7.2 Catalent Business Overview 93
11.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Introduction 93
11.7.4 Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 94
11.8 Sterling Pharma Solutions 95
11.8.1 Sterling Pharma Solutions Company Details 95
11.8.2 Sterling Pharma Solutions Business Overview 95
11.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction 96
11.8.4 Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 96
11.9 Curia 97
11.9.1 Curia Company Details 97
11.9.2 Curia Business Overview 98
11.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Introduction 98
11.9.4 Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 99
11.10 Novasep 100
11.10.1 Novasep Company Details 100
11.10.2 Novasep Business Overview 100
11.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Introduction 101
11.10.4 Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 103
11.11 Ajinomoto Bio-Pharma Services 104
11.11.1 Ajinomoto Bio-Pharma Services Company Details 104
11.11.2 Ajinomoto Bio-Pharma Services Business Overview 104
11.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Introduction 105
11.11.4 Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 107
11.12 BSP Pharmaceuticals 107
11.12.1 BSP Pharmaceuticals Company Details 108
11.12.2 BSP Pharmaceuticals Business Overview 108
11.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Introduction 109
11.12.4 BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 110
11.13 Cerbios-Pharma 111
11.13.1 Cerbios-Pharma Company Details 111
11.13.2 Cerbios-Pharma Business Overview 112
11.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Introduction 112
11.13.4 Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 113
11.14 GBI (Goodwin Biotechnology) 114
11.14.1 GBI (Goodwin Biotechnology) Company Details 114
11.14.2 GBI (Goodwin Biotechnology) Business Overview 115
11.14.3 GBI (Goodwin Biotechnology) Antibody Drug Conjugates Contract Manufacturing Introduction 115
11.14.4 GBI (Goodwin Biotechnology) Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 116
12 Analyst's Viewpoints/Conclusions 118
13 Appendix 119
13.1 Research Methodology 119
13.1.1 Methodology/Research Approach 119
13.1.2 Data Source 122
13.2 Author Details 125
13.3 Disclaimer 128

鈥

List of Figure

Table 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033 3
Table 2. Key Players of IgG1 4
Table 3. Key Players of IgG4 5
Table 4. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033 5
Table 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033 12
Table 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million) 13
Table 7. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2018-2023) 13
Table 8. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2024-2033) & (US$ Million) 13
Table 9. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2024-2033) 14
Table 10. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2018-2023) & (US$ Million) 18
Table 11. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players (2018-2023) 19
Table 12. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2021) 21
Table 13. Global Antibody Drug Conjugates Contract Manufacturing Industry Ranking 2021 VS 2023 VS 2023 22
Table 14. Global 5 Largest Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue (CR5 and HHI) & (2018-2023) 24
Table 15. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Headquarters and Area Served 25
Table 16. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application 26
Table 17. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Established 27
Table 18. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million) 28
Table 19. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2018-2023) 28
Table 20. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2024-2033) & (US$ Million) 29
Table 21. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2024-2033) 29
Table 22. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million) 30
Table 23. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2018-2023) 30
Table 24. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2024-2033) & (US$ Million) 31
Table 25. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2024-2033) 31
Table 26. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million) 32
Table 27. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) & (US$ Million) 33
Table 28. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million) 34
Table 29. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) & (US$ Million) 34
Table 30. North America Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033 35
Table 31. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million) 36
Table 32. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2033) & (US$ Million) 36
Table 33. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million) 39
Table 34. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) & (US$ Million) 40
Table 35. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million) 41
Table 36. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) & (US$ Million) 41
Table 37. Europe Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033 42
Table 38. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million) 43
Table 39. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2033) & (US$ Million) 43
Table 40. China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million) 49
Table 41. China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) & (US$ Million) 50
Table 42. China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million) 51
Table 43. China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) & (US$ Million) 51
Table 44. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million) 53
Table 45. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) & (US$ Million) 54
Table 46. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million) 55
Table 47. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) & (US$ Million) 55
Table 48. Asia Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033 56
Table 49. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2018-2023) & (US$ Million) 57
Table 50. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2024-2033) & (US$ Million) 57
Table 51. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2018-2023) & (US$ Million) 63
Table 52. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2024-2033) & (US$ Million) 64
Table 53. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2018-2023) & (US$ Million) 65
Table 54. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2024-2033) & (US$ Million) 65
Table 55. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033 66
Table 56. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2018-2023) & (US$ Million) 67
Table 57. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2024-2033) & (US$ Million) 67
Table 58. Lonza Group Company Details 73
Table 59. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product 74
Table 60. Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 75
Table 61. Merck Company Details 76
Table 62. Merck Antibody Drug Conjugates Contract Manufacturing Product 77
Table 63. Merck Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 78
Table 64. Recipharm Company Details 79
Table 65. Recipharm Antibody Drug Conjugates Contract Manufacturing Product 80
Table 66. Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 81
Table 67. Thermo Fisher Scientific Company Details 82
Table 68. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product 83
Table 69. Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 84
Table 70. Abbvie Company Details 85
Table 71. Abbvie Antibody Drug Conjugates Contract Manufacturing Product 85
Table 72. Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 87
Table 73. Piramal Pharma Solutions Company Details 88
Table 74. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product 89
Table 75. Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 91
Table 76. Catalent Company Details 92
Table 77. Catalent Antibody Drug Conjugates Contract Manufacturing Product 93
Table 78. Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 94
Table 79. Sterling Pharma Solutions Company Details 95
Table 80. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product 96
Table 81. Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 96
Table 82. Curia Company Details 97
Table 83. Curia Antibody Drug Conjugates Contract Manufacturing Product 98
Table 84. Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 99
Table 85. Novasep Company Details 100
Table 86. Novasep Antibody Drug Conjugates Contract Manufacturing Product 101
Table 87. Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 103
Table 88. Ajinomoto Bio-Pharma Services Company Details 104
Table 89. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product 105
Table 90. Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 107
Table 91. BSP Pharmaceuticals Company Details 108
Table 92. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product 109
Table 93. BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 110
Table 94. Cerbios-Pharma Company Details 111
Table 95. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product 112
Table 96. Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 113
Table 97. GBI (Goodwin Biotechnology) Company Details 114
Table 98. GBI (Goodwin Biotechnology) Antibody Drug Conjugates Contract Manufacturing Product 115
Table 99. GBI (Goodwin Biotechnology) Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) & (US$ Million) 116
Table 100. Research Programs/Design for This Report 119
Table 101. Key Data Information from Secondary Sources 122
Table 102. Key Data Information from Primary Sources 124
Table 103. QYR Business Unit and Senior & Team Lead Analysts 125

鈥
List of Figures

Figure 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million) 3
Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Type: 2023 VS 2033 4
Figure 3. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million) 6
Figure 4. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2023 VS 2033 7
Figure 5. Antibody Drug Conjugates Contract Manufacturing Report Years Considered 9
Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2033 10
Figure 7. Global Antibody Drug Conjugates Contract Manufacturing Market Size, (US$ Million), 2018 VS 2023 VS 2033 11
Figure 8. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region: 2023 VS 2033 12
Figure 9. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players in 2023 20
Figure 10. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2023) 22
Figure 11. The Top 10 and 5 Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue in 2023 24
Figure 12. North America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 32
Figure 13. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 33
Figure 14. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 35
Figure 15. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2033) 37
Figure 16. United States Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 37
Figure 17. Canada Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 38
Figure 18. Europe Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 39
Figure 19. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 40
Figure 20. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 42
Figure 21. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2033) 44
Figure 22. Germany Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 45
Figure 23. France Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 45
Figure 24. U.K. Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 46
Figure 25. Italy Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 47
Figure 26. Russia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 47
Figure 27. Nordic Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 48
Figure 28. China Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 49
Figure 29. China Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 50
Figure 30. China Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 52
Figure 31. Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 53
Figure 32. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 54
Figure 33. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 56
Figure 34. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2018-2033) 58
Figure 35. Japan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 59
Figure 36. South Korea Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 59
Figure 37. China Taiwan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 60
Figure 38. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 61
Figure 39. India Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 61
Figure 40. Australia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 62
Figure 41. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 63
Figure 42. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2018-2033) 64
Figure 43. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2018-2033) 66
Figure 44. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2018-2033) 68
Figure 45. Brazil Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 69
Figure 46. Mexico Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 69
Figure 47. Turkey Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 70
Figure 48. Israel Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 71
Figure 49. GCC Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2018-2033) & (US$ Million) 71
Figure 50. Lonza Group Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 76
Figure 51. Merck Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 79
Figure 52. Recipharm Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 82
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 84
Figure 54. Abbvie Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 88
Figure 55. Piramal Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 92
Figure 56. Catalent Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 94
Figure 57. Sterling Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 97
Figure 58. Curia Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 99
Figure 59. Novasep Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 103
Figure 60. Ajinomoto Bio-Pharma Services Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 107
Figure 61. BSP Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 111
Figure 62. Cerbios-Pharma Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 114
Figure 63. GBI (Goodwin Biotechnology) Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2018-2023) 116
Figure 64. Bottom-up and Top-down Approaches for This Report 121
Figure 65. Data Triangulation 122
Figure 66. Key Executives Interviewed 124

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries